Patients on TNFi or IL-17i have lower odds of achieving treatment outcomes with comorbid obesity and history of diabetes

Panel of serum protein biomarkers identified and evaluated for potential use in diagnostic testing for early-onset psoriatic arthritis

Definition includes five domains of management of clinical symptoms, psychosocial elements, QoL, treatment, health care team support

Dupilumab can help patients achieve adequate disease control and reduce use of other therapies

Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria

Fourteen of the first 43 cases reported international travel during the 14 days preceding symptom onset or positive test result

Risk for hospital admission among adults with COVID-19 29 percent lower than in the first pandemic wave that began in March 2020

Adding dupilumab versus placebo reduced exacerbations, improved lung function in children with uncontrolled moderate-to-severe asthma

Response rate higher but more adverse events seen at week 12 in patients with plaque psoriasis receiving tapinarof versus vehicle control

22 percent of patients who had delay to MMS due to stay-at-home order were more worried about their cancer

More than 20 therapies were tried in a case series of 95 patients; 19 percent reported hospitalization during follow-up

Improvement in lesional scalp transcriptome toward nonlesional profile seen at week 24 for both ritlecitinib, brepocitinib

Risk particularly high in women and individuals with psoriatic arthritis

Increases in medical exemptions result in more than twice as many infections than if exemptions were maintained at pre-policy change level

However, telemedicine visits associated with fewer medication prescriptions, orders for laboratory tests or imaging

Checklist for evaluation of image-based AI reports grouped into topics of data, technique, technical assessment, application

BF-200 ALA has high efficacy, excellent cosmetic outcome for patients with mild-to-severe actinic keratoses located on extremities, trunk, neck

Two-year overall survival 72 percent for those starting with N/I, 52 percent for those starting with dabrafenib/trametinib

Proctor & Gamble said that it has not received any reports of harm from the recalled products

In subgroup analysis according to sex, increased risk for CRC seen for female, but not male psoriasis patients

So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant

Men twice as likely to have soaps as source of PCP, while hair care products were twice as likely to be a source among...

Patient-led surveillance correlated with increased skin self-examination frequency, had no adverse impact on psychological outcomes